US$ 22.04
canlab bpc 157 BPC-157 – LIVE ALPHA LABS Peptide BPC-157 - Does It
Description
To deliver rivastigmine to treat Alzheimers disease via the nose-to-brain route, Cunha et al developed different lipid-based nanoparticles, nanoemulsions (RIV-NE), and NLCs (RIV-NLC)

Preexisting heterogeneity of inducible nitric oxide synthase expression drives differential growth of Mycobacterium tuberculosis in macrophages

Researchers note that intranasal delivery may especially increase the bioavailability of peptide therapeutics and present an appealing alternative to injection [14, 15, 16]

Review Manager (RevMan)
